Tenax Therapeutics, Inc. (TENX)

NASDAQ: TENX · Real-Time Price · USD

5.68

+0.01 (0.18%)

At close: May 14, 2025, 4:00 PM

5.70

+0.02 (0.35%)

After-hours: May 14, 2025, 6:41 PM EDT

Tenax Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Selling, General & Admin	6.79	5.01	5.68	6.38	5.31	Upgrade
Research & Development	12.71	3.23	5.38	25.15	4.56	Upgrade
Operating Expenses	19.49	8.23	11.05	31.53	9.87	Upgrade
Operating Income	-19.49	-8.23	-11.05	-31.53	-9.87	Upgrade
Interest Expense	-0.02	-0.02	-0	-0	-0	Upgrade
Interest & Investment Income	1.91	0.48	-	-	-	Upgrade
Other Non Operating Income (Expenses)	0	0.06	0.01	0.02	0.03	Upgrade
EBT Excluding Unusual Items	-17.6	-7.71	-11.05	-31.51	-9.84	Upgrade
Gain (Loss) on Sale of Investments	-	-	-	-0.01	-0.01	Upgrade
Gain (Loss) on Sale of Assets	-	-	0	-	-	Upgrade
Other Unusual Items	-	-	-	-0.95	-	Upgrade
Pretax Income	-17.6	-7.71	-11.05	-32.47	-9.85	Upgrade
Net Income	-17.6	-7.71	-11.05	-32.47	-9.85	Upgrade
Net Income to Common	-17.6	-7.71	-11.05	-32.47	-9.85	Upgrade
Shares Outstanding (Basic)	15	0	0	0	-	Upgrade
Shares Outstanding (Diluted)	15	0	0	0	-	Upgrade
Shares Change (YoY)	6046.87%	1250.92%	43.00%	-	-	Upgrade
EPS (Basic)	-1.15	-31.04	-600.72	-2525.03	-	Upgrade
EPS (Diluted)	-1.15	-31.04	-600.72	-2525.03	-	Upgrade
Free Cash Flow	-14.81	-5.9	-11.39	-10.86	-9.28	Upgrade
Free Cash Flow Per Share	-0.97	-23.76	-619.37	-844.53	-	Upgrade
EBITDA	-19.49	-8.23	-11.05	-31.52	-9.86	Upgrade
D&A For EBITDA	0.01	0.01	0.01	0	0	Upgrade
EBIT	-19.49	-8.23	-11.05	-31.53	-9.87	Upgrade

Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q